Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603420 · ClinicalTrials.gov registry record · Phase 2
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
A Phase 2 study, sponsored by Proton Collaborative Group.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01603420 is a Phase 2 study that was terminated before completion, run by Proton Collaborative Group. The registered enrollment target is 2 participants.
The verdict
NCT01603420, a Phase 2 study, was terminated before completion, sponsored by Proton Collaborative Group.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects on prostate cancer using radiation therapy with or without chemotherapy.
Interventions
- DRUG Docetaxel
- DRUG Luteinizing hormone-releasing hormone (LHRH)
- OTHER Conformal Radiation Therapy (RT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01603420
The ClinicalTrials.gov registry entry for NCT01603420 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Proton Collaborative Group, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Docetaxel is the first listed.
NCT01603420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01603420 about?
NCT01603420 is a clinical study titled "External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer". The purpose of this study is to compare the effects on prostate cancer using radiation therapy with or without chemotherapy.
What is the current status of trial NCT01603420?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2012-07. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01603420?
The interventions under investigation include: Docetaxel (DRUG), Luteinizing hormone-releasing hormone (LHRH) (DRUG), Conformal Radiation Therapy (RT) (OTHER).
Who is sponsoring clinical trial NCT01603420?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.